Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
221 - 230 out of 415Page size: 10
  1. 2019
  2. Published

    Dapagliflozin plus saxagliptin add-on therapy compared with insulin in patients with type 2 diabetes poorly controlled by metformin with or without sulfonylurea therapy: A randomized clinical trial

    Vilsbøll, Tina, Ekholm, E., Johnsson, E., Dronamraju, N., Jabbour, S. & Lind, M., 2019, In: Diabetes Care. 42, 8, p. 1464-1472 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Data on the use of dietary supplements in Danish patients with type 1 and type 2 diabetes

    Ewers, B., Trolle, E., Jacobsen, S. S., Vististen, D., Almdal, Thomas Peter, Vilsbøll, Tina & Bruun, J. M., 2019, In: Data in Brief. 22, p. 241-244 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Dietary habits and adherence to dietary recommendations in patients with type 1 and type 2 diabetes compared with the general population in Denmark

    Ewers, B., Trolle, E., Jacobsen, S. S., Vististen, D., Almdal, Thomas Peter, Vilsbøll, Tina & Bruun, J. M., 2019, In: Nutrition. 61, p. 49-55 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES

    Lingvay, I., Handelsman, Y., Linjawi, S., Vilsbøll, Tina, Halladin, N., Ranc, K. & Liebl, A., 2019, In: Endocrine Practice. 25, 2, p. 144-155

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): Study protocol for a randomised, parallel open-label, intervention study focusing on HbA1c and glucose variability in patients with type 2 diabetes

    Ewers, B., Bruun, J. M. & Vilsbøll, Tina, 2019, In: BMJ Open. 9, 11, 9 p., e032893.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

    Bergmann, N. C., Lund, A., Gasbjerg, Lærke Smidt, Meessen, E. C. E., Andersen, M. M., Bergmann, S., Hartmann, Bolette, Holst, Jens Juul, Jessen, L., Christensen, Mikkel Bring, Vilsbøll, Tina & Knop, Filip Krag, 2019, In: Diabetologia. 62, 4, p. 665-675 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Endogenous glucose-dependent insulinotropic polypeptide exerts diverging and tissue specific in obese patients with type 2 diabetes

    Stensen, S., Gasbjerg, Lærke Smidt, Krogh, L. L., wbf943, wbf943, Skov-Jeppesen, Kirsa, Jensen, M. H., Hartmann, Bolette, Vilsbøll, Tina, Holst, Jens Juul, Rosenkilde, Mette, Christensen, M. B. & Knop, Filip Krag, 2019, In: Diabetologia. 62, Supl. 1/SI, p. S270-S271 2 p., 560.

    Research output: Contribution to journal › Conference abstract in journal › Research

  9. Published

    Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes

    Christensen, R. H., Von Scholten, B. J., Hansen, C. S., Jensen, M. T., Vilsbøll, Tina, Rossing, Peter & Jørgensen, P. G., 2019, In: Cardiovascular Diabetology. 18, 10 p., 114.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes

    Christensen, R. H., Hansen, C. S., von Scholten, B. J., Jensen, M. T., Pedersen, Bente Klarlund, Schnohr, P., Vilsbøll, Tina, Rossing, Peter & Jørgensen, P. G., 2019, In: Diabetes, Obesity and Metabolism. 21, 8, p. 2006-2011

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

    Vilsbøll, Tina, Blevins, T. C., Jodar, E., Poulter, N., Tentolouris, N., Ross Agner, B. F., Lehmann, L. & Leiter, L. A., 2019, In: Diabetes, Obesity and Metabolism. 21, 6, p. 1506-1512 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...19 20 21 22 23 24 25 26 ...42 Next

ID: 33056950